Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

The combination of cisplatin or carboplatin and etoposide is the standard treatment for certain poorly differentiated neuroendocrine cancers, such as small-cell lung cancer. The aim of this study was to assess the efficacy and tolerability of the carboplatin-etoposide regimen in metastatic castratio...

Descripción completa

Detalles Bibliográficos
Autores principales: CAUBET, MATTHIEU, DOBI, ERION, POZET, ASTRID, ALMOTLAK, HAMADI, MONTCUQUET, PHILIPPE, MAURINA, TRISTAN, MOUILLET, GUILLAUME, N'GUYEN, THIERRY, STEIN, ULRICH, THIERY-VUILLEMIN, ANTOINE, FITENI, FREDERIC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665308/
https://www.ncbi.nlm.nih.gov/pubmed/26807222
http://dx.doi.org/10.3892/mco.2015.628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665308/
https://www.ncbi.nlm.nih.gov/pubmed/26807222
http://dx.doi.org/10.3892/mco.2015.628

Ejemplares similares